LA
Genomma Lab Internacional, S.A.B. de C.V.
LABB.MX · MEX
13.11 $ +0.23% (+0.03 $)
1M -8.60%
Market Cap 12.8B $
P/E Ratio 7.87x
Div. Yield -
ROE 14.23%
Bulios Fair Price
15.79 $
20.4% upside
Trenutna cena
13.11 $
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LABB.MX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
99 /100
Cheap P/E 7.87x
EV/EBITDA 4.88x
P/S 0.75x
Growth
33 /100
Declining EPS growth 5.63%
Rev. growth 1.41%
FCF growth 0.12%
Profitability
73 /100
Strong Gross margin 63.25%
Net margin 9.52%
Op. margin 20.26%
Quality
64 /100
Average ROIC 11.76%
ROE 14.23%
ROA 6.71%
Debt
67 /100
Low Debt/Equity 0.67x
Current ratio 1.41x
Int. coverage 3.68x
Stability
64 /100
Moderate Beta 0.14x
Rev. volatility 9.93%
EPS volatility 27.34%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LABB.MX
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Juan Marco Sparvieri
Employees
1,465
Headquarters
Mexico City
Prihajajoči dogodki
21 OKT.
Earnings
Upcoming earnings report